Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery
This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery. Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve repl...
Saved in:
| Published in | Journal of the American College of Cardiology Vol. 63; no. 19; pp. 1972 - 1981 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Elsevier Inc
20.05.2014
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery.
Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy.
We performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG).
A total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis).
TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902) |
|---|---|
| AbstractList | This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery.
Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy.
We performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG).
A total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis).
TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902). Objectives This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery. Background Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy. Methods We performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG). Results A total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis). Conclusions TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement;NCT01240902) This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery.OBJECTIVESThis study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery.Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy.BACKGROUNDUntreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy.We performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG).METHODSWe performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG).A total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis).RESULTSA total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis).TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902).CONCLUSIONSTAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902). ObjectivesThis study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery. BackgroundUntreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy. MethodsWe performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG). ResultsA total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis). ConclusionsTAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902) This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery. Untreated severe aortic stenosis is a progressive disease with a poor prognosis. Transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis is a potentially effective therapy. We performed a prospective, multicenter, nonrandomized investigation evaluating the safety and efficacy of self-expanding TAVR in patients with symptomatic severe aortic stenosis with prohibitive risks for surgery. The primary endpoint was a composite of all-cause mortality or major stroke at 12 months, which was compared with a pre-specified objective performance goal (OPG). A total of 41 sites in the United States recruited 506 patients, of whom 489 underwent attempted treatment with the CoreValve THV. The rate of all-cause mortality or major stroke at 12 months was 26.0% (upper 2-sided 95% confidence bound: 29.9%) versus 43.0% with the OPG (p < 0.0001). Individual 30-day and 12-month events included all-cause mortality (8.4% and 24.3%, respectively) and major stroke (2.3% and 4.3%, respectively). Procedural events at 30 days included life-threatening/disabling bleeding (12.7%), major vascular complications (8.2%), and need for permanent pacemaker placement (21.6%). The frequency of moderate or severe paravalvular aortic regurgitation was lower 12 months after self-expanding TAVR (4.2%) than at discharge (10.7%; p = 0.004 for paired analysis). TAVR with a self-expanding bioprosthesis was safe and effective in patients with symptomatic severe aortic stenosis at prohibitive risk for surgical valve replacement. (Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement; NCT01240902) |
| Author | Conte, John Hughes, G. Chad Adams, David H. Kleiman, Neal S. Heimansohn, David Harrison, J. Kevin Yakubov, Steven J. Coselli, Joseph Carabello, Blasé Popma, Jeffrey J. Kafi, Ali Buchbinder, Maurice Deeb, G. Michael Reardon, Michael J. Diez, Jose Schreiber, Theodore Serruys, Patrick W. Oh, Jae K. Hermiller, James Gleason, Thomas G. Chenoweth, Sharla |
| Author_xml | – sequence: 1 givenname: Jeffrey J. surname: Popma fullname: Popma, Jeffrey J. email: jpopma@bidmc.harvard.edu organization: Beth Israel Deaconess Medical Center, Boston, Massachusetts – sequence: 2 givenname: David H. surname: Adams fullname: Adams, David H. organization: Mount Sinai Medical Center, New York, New York – sequence: 3 givenname: Michael J. surname: Reardon fullname: Reardon, Michael J. organization: Houston-Methodist-Debakey Heart and Vascular Center, Houston, Texas – sequence: 4 givenname: Steven J. surname: Yakubov fullname: Yakubov, Steven J. organization: Riverside Methodist Hospital, Columbus, Ohio – sequence: 5 givenname: Neal S. surname: Kleiman fullname: Kleiman, Neal S. organization: Houston-Methodist-Debakey Heart and Vascular Center, Houston, Texas – sequence: 6 givenname: David surname: Heimansohn fullname: Heimansohn, David organization: St. Vincent's Medical Center, Indianapolis, Indiana – sequence: 7 givenname: James surname: Hermiller fullname: Hermiller, James organization: St. Vincent's Medical Center, Indianapolis, Indiana – sequence: 8 givenname: G. Chad surname: Hughes fullname: Hughes, G. Chad organization: Duke University Medical Center, Durham, North Carolina – sequence: 9 givenname: J. Kevin surname: Harrison fullname: Harrison, J. Kevin organization: Duke University Medical Center, Durham, North Carolina – sequence: 10 givenname: Joseph surname: Coselli fullname: Coselli, Joseph organization: Texas Heart Institute at St. Luke's Medical Center, Houston, Texas – sequence: 11 givenname: Jose surname: Diez fullname: Diez, Jose organization: Texas Heart Institute at St. Luke's Medical Center, Houston, Texas – sequence: 12 givenname: Ali surname: Kafi fullname: Kafi, Ali organization: Detroit Medical Center, Detroit, Michigan – sequence: 13 givenname: Theodore surname: Schreiber fullname: Schreiber, Theodore organization: Detroit Medical Center, Detroit, Michigan – sequence: 14 givenname: Thomas G. surname: Gleason fullname: Gleason, Thomas G. organization: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania – sequence: 15 givenname: John surname: Conte fullname: Conte, John organization: Johns Hopkins Medical Center, Baltimore, Maryland – sequence: 16 givenname: Maurice surname: Buchbinder fullname: Buchbinder, Maurice organization: Palo Alto Veterans Administration Medical Center, Palo Alto, California – sequence: 17 givenname: G. Michael surname: Deeb fullname: Deeb, G. Michael organization: University of Michigan Medical Center, Ann Arbor, Michigan – sequence: 18 givenname: Blasé surname: Carabello fullname: Carabello, Blasé organization: Baylor College of Medicine, Houston Texas – sequence: 19 givenname: Patrick W. surname: Serruys fullname: Serruys, Patrick W. organization: Thoraxcenter, Rotterdam, the Netherlands – sequence: 20 givenname: Sharla surname: Chenoweth fullname: Chenoweth, Sharla organization: Medtronic, Inc., Minneapolis, Minnesota – sequence: 21 givenname: Jae K. surname: Oh fullname: Oh, Jae K. organization: Mayo Clinic Foundation, Rochester, Minnesota |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28548586$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24657695$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkt9q2zAYxc3oWNNuL7CLIRiD3TiTbEuWRxl0JfsDhY2m3S6FLH9qlTpyJsmheY09QZ4lTzaZpCsE1l0JxO8cfTrnO0oObGchSV4SPCaYsHez8UwqNc4wKcY4G1PKniQjQilPc1qVB8kIlzlNCa7Kw-TI-xnGmHFSPUsOs4LRklV0lPy-dNJ6JcMNBHDotHPBKPRDtktAF7BopYI52ICuvLHXm7XcrKfQ6nRyt5C2iVfoo-kWrvNR741HxqLvMpio8OinCTdoCktwcO87DWC7gZMBTe6Ci96b9YXxt0h3Dk17dw1u9Tx5qmXr4cXuPE6uPk0uz76k598-fz07PU8VzXBIgfOal1KTgnDdEF5WDJiUdQ11A8CyuiyVhkzXTGOSs4ZoJQutalC0aDil-XHydusb5__Vgw9ibryCtpUWut4LQrMYUl5gHNHXe-is652N0w1UzquCUBKpVzuqr-fQiIUzc-lW4j7tCLzZATJG3uoYvTL-geO04JSzyGVbTsVkvQP9FyFYDNWLmRiqF0P1AmciVh9FfE-kTIhddDY4adrHpSdbKcS4lwac8Cp2qKAxDlQQTWcel3_Yk6vWWBN_eAsr8A9RCZ8JLKbDWg5bSYpYTMWGXN7_2-B_r_8B1M_2cA |
| CODEN | JACCDI |
| CitedBy_id | crossref_primary_10_1016_j_xjon_2022_07_009 crossref_primary_10_4244_EIJ_D_22_00498 crossref_primary_10_1016_j_fmc_2017_10_005 crossref_primary_10_2139_ssrn_4100676 crossref_primary_10_1016_j_jcin_2015_05_015 crossref_primary_10_1253_circj_CJ_21_0877 crossref_primary_10_1016_j_jcin_2018_11_008 crossref_primary_10_1016_j_jacc_2015_07_042 crossref_primary_10_1016_j_jcin_2017_09_035 crossref_primary_10_1097_HCR_0000000000000301 crossref_primary_10_1016_j_jcmg_2015_03_011 crossref_primary_10_1016_j_carrev_2018_05_004 crossref_primary_10_1016_j_jcmg_2015_11_010 crossref_primary_10_1016_j_jacc_2016_02_057 crossref_primary_10_2217_fca_2017_0031 crossref_primary_10_1016_j_amjcard_2023_09_090 crossref_primary_10_1161_CIRCULATIONAHA_120_046159 crossref_primary_10_1007_s12055_020_01107_8 crossref_primary_10_1016_j_ijcard_2024_131792 crossref_primary_10_1016_j_carrev_2021_12_009 crossref_primary_10_1093_ejcts_ezw218 crossref_primary_10_1093_ehjqcco_qcx014 crossref_primary_10_1093_icvts_ivx355 crossref_primary_10_1016_j_amjcard_2015_06_014 crossref_primary_10_1007_s00059_018_4778_z crossref_primary_10_1016_j_ijcha_2022_101101 crossref_primary_10_1253_circj_CJ_19_0823 crossref_primary_10_1016_j_jacc_2015_06_026 crossref_primary_10_1016_j_jtcvs_2020_10_007 crossref_primary_10_1007_s11883_016_0577_2 crossref_primary_10_1007_s11926_020_00898_4 crossref_primary_10_1016_j_ahj_2021_09_011 crossref_primary_10_1016_S0140_6736_24_00821_3 crossref_primary_10_1161_CIRCULATIONAHA_114_012740 crossref_primary_10_1016_j_cjca_2023_11_037 crossref_primary_10_12688_f1000research_11906_1 crossref_primary_10_3904_kjim_2018_015 crossref_primary_10_1016_j_amjcard_2018_05_044 crossref_primary_10_1038_nrdp_2016_6 crossref_primary_10_3390_jcm9113392 crossref_primary_10_1530_ERP_17_0080 crossref_primary_10_1093_icvts_ivz306 crossref_primary_10_1161_JAHA_119_013352 crossref_primary_10_4244_EIJ_D_20_01293 crossref_primary_10_1016_j_cjca_2017_06_013 crossref_primary_10_1016_j_jcmg_2015_12_022 crossref_primary_10_1056_NEJMra1510063 crossref_primary_10_2217_fca_2017_0048 crossref_primary_10_1111_jocs_12814 crossref_primary_10_1016_j_jcin_2018_11_036 crossref_primary_10_1161_CIRCULATIONAHA_117_026547 crossref_primary_10_1093_ehjci_jew321 crossref_primary_10_3390_jcdd9070223 crossref_primary_10_1136_heartjnl_2018_313511 crossref_primary_10_1007_s11936_019_0799_z crossref_primary_10_1016_j_athoracsur_2015_06_083 crossref_primary_10_2217_fca_15_86 crossref_primary_10_1002_ccd_25904 crossref_primary_10_1053_j_jvca_2021_11_034 crossref_primary_10_1111_jocs_13938 crossref_primary_10_3389_fcvm_2018_00091 crossref_primary_10_1016_j_jcin_2018_10_007 crossref_primary_10_17925_HI_2021_15_2_79 crossref_primary_10_1016_j_ijcard_2015_06_002 crossref_primary_10_1016_j_athoracsur_2017_07_051 crossref_primary_10_1016_j_athoracsur_2020_06_018 crossref_primary_10_11622_smedj_2016097 crossref_primary_10_1001_jamasurg_2019_4449 crossref_primary_10_1093_ehjqcco_qcx026 crossref_primary_10_1161_CIRCINTERVENTIONS_116_003830 crossref_primary_10_1161_JAHA_119_014020 crossref_primary_10_1177_2040622320949068 crossref_primary_10_1016_j_jcin_2024_01_292 crossref_primary_10_1016_j_cmi_2020_01_028 crossref_primary_10_1007_s11739_021_02752_6 crossref_primary_10_1161_CIRCINTERVENTIONS_118_006664 crossref_primary_10_1001_jama_2019_8613 crossref_primary_10_1016_j_jcin_2018_10_017 crossref_primary_10_1002_ccd_29499 crossref_primary_10_1016_j_hlc_2020_05_096 crossref_primary_10_1016_j_jchf_2023_07_003 crossref_primary_10_1093_eurheartj_ehw112 crossref_primary_10_1016_j_rbci_2016_07_001 crossref_primary_10_3390_jcm10215046 crossref_primary_10_1016_j_ccl_2019_09_007 crossref_primary_10_1016_j_jcin_2018_10_030 crossref_primary_10_1097_HCO_0000000000000531 crossref_primary_10_1080_24748706_2019_1670885 crossref_primary_10_1161_JAHA_117_008463 crossref_primary_10_1253_circrep_CR_24_0020 crossref_primary_10_1016_j_echo_2019_01_003 crossref_primary_10_1161_HCQ_0000000000000129 crossref_primary_10_2459_JCM_0000000000001172 crossref_primary_10_4103_2468_5658_196983 crossref_primary_10_1016_S0140_6736_16_00586_9 crossref_primary_10_1016_j_ijcard_2017_10_101 crossref_primary_10_1016_j_athoracsur_2017_07_017 crossref_primary_10_1016_j_recesp_2021_11_027 crossref_primary_10_2217_fca_15_73 crossref_primary_10_1016_j_jtcvs_2018_11_129 crossref_primary_10_1016_j_jacc_2016_10_023 crossref_primary_10_1016_j_jacc_2016_10_024 crossref_primary_10_2217_fca_2018_0064 crossref_primary_10_1093_eurheartj_ehv281 crossref_primary_10_1001_jamacardio_2024_4278 crossref_primary_10_1016_j_athoracsur_2022_09_028 crossref_primary_10_1007_s00059_016_4461_1 crossref_primary_10_1016_j_jcin_2017_07_027 crossref_primary_10_1007_s11936_023_01020_4 crossref_primary_10_1016_j_acmx_2015_07_004 crossref_primary_10_1016_j_jcin_2017_07_025 crossref_primary_10_1016_j_recesp_2015_08_018 crossref_primary_10_1016_j_rbciev_2017_02_005 crossref_primary_10_1016_j_jcmg_2015_01_001 crossref_primary_10_1016_j_jcin_2015_11_003 crossref_primary_10_1016_j_carrev_2021_03_015 crossref_primary_10_3390_surgeries6010004 crossref_primary_10_1016_j_athoracsur_2018_04_029 crossref_primary_10_1161_CIRCINTERVENTIONS_119_008231 crossref_primary_10_1093_eurheartj_ehx031 crossref_primary_10_1053_j_jvca_2014_09_003 crossref_primary_10_1016_j_amjcard_2015_04_016 crossref_primary_10_1016_j_tcm_2019_07_001 crossref_primary_10_1001_jamacardio_2019_4386 crossref_primary_10_1016_j_ahj_2019_02_007 crossref_primary_10_1007_s11910_020_01033_7 crossref_primary_10_1177_15569845211017558 crossref_primary_10_1016_j_jtcvs_2014_07_020 crossref_primary_10_3390_jcm8020280 crossref_primary_10_36660_abc_20230551 crossref_primary_10_1016_j_amjmed_2014_10_054 crossref_primary_10_1016_j_carrev_2023_07_024 crossref_primary_10_1080_08998280_2018_1482515 crossref_primary_10_2217_bmm_2018_0097 crossref_primary_10_1016_j_amjcard_2018_02_008 crossref_primary_10_1080_14779072_2017_1297230 crossref_primary_10_1371_journal_pone_0224815 crossref_primary_10_1093_eurheartj_ehw153 crossref_primary_10_1161_CIRCINTERVENTIONS_115_003563 crossref_primary_10_1007_s40119_017_0100_z crossref_primary_10_1016_j_amjcard_2015_12_009 crossref_primary_10_1016_j_carrev_2019_01_026 crossref_primary_10_1016_j_jtcvs_2016_07_013 crossref_primary_10_1016_j_jacc_2021_11_062 crossref_primary_10_1097_CRD_0000000000000177 crossref_primary_10_1016_j_carrev_2019_01_020 crossref_primary_10_1016_j_echo_2017_01_003 crossref_primary_10_1136_openhrt_2016_000414 crossref_primary_10_1016_j_jacc_2015_05_016 crossref_primary_10_1016_j_jacc_2015_05_017 crossref_primary_10_1111_pace_13789 crossref_primary_10_1016_j_athoracsur_2015_11_031 crossref_primary_10_2217_fca_2019_0084 crossref_primary_10_1093_eurheartj_ehw165 crossref_primary_10_1016_j_cger_2019_07_007 crossref_primary_10_1016_j_med_2017_09_008 crossref_primary_10_33529_ANGIO2021311 crossref_primary_10_1002_ejhf_2333 crossref_primary_10_1016_j_athoracsur_2015_06_067 crossref_primary_10_1053_j_pcsu_2015_12_002 crossref_primary_10_1016_j_cnc_2019_04_002 crossref_primary_10_1053_j_jvca_2016_10_009 crossref_primary_10_1177_1556984520971775 crossref_primary_10_1053_j_semtcvs_2014_10_001 crossref_primary_10_1161_CIRCINTERVENTIONS_122_012538 crossref_primary_10_4137_CMC_S15716 crossref_primary_10_1136_openhrt_2017_000748 crossref_primary_10_1016_j_cjca_2019_08_011 crossref_primary_10_1097_MD_0000000000034478 crossref_primary_10_1161_CIRCRESAHA_121_318040 crossref_primary_10_1055_s_0040_1722692 crossref_primary_10_1002_ccd_30094 crossref_primary_10_1002_ccd_27928 crossref_primary_10_1002_ccd_26837 crossref_primary_10_1002_ccd_25749 crossref_primary_10_3389_fcvm_2024_1374078 crossref_primary_10_1016_j_athoracsur_2015_07_030 crossref_primary_10_1016_j_jtcvs_2017_04_090 crossref_primary_10_1016_j_rec_2016_06_004 crossref_primary_10_23736_S0021_9509_18_10651_3 crossref_primary_10_1530_ERP_17_0050 crossref_primary_10_4070_kcj_2022_0234 crossref_primary_10_1016_j_jcin_2015_12_026 crossref_primary_10_29001_2073_8552_2019_34_3_153_160 crossref_primary_10_1016_j_jacc_2020_09_605 crossref_primary_10_15406_jccr_2017_08_00284 crossref_primary_10_1161_JAHA_115_002135 crossref_primary_10_12688_f1000research_8728_1 crossref_primary_10_1016_j_jcin_2015_12_271 crossref_primary_10_1093_ejcts_ezv169 crossref_primary_10_1016_j_jacasi_2022_09_003 crossref_primary_10_1016_j_jacc_2016_03_526 crossref_primary_10_4244_AIJ_D_23_00017 crossref_primary_10_1007_s40256_015_0110_y crossref_primary_10_1001_jamacardio_2021_2534 crossref_primary_10_1002_ccd_27708 crossref_primary_10_1161_CIRCULATIONAHA_116_025103 crossref_primary_10_1002_ccd_25765 crossref_primary_10_1016_j_jcct_2018_03_007 crossref_primary_10_1161_JAHA_121_024377 crossref_primary_10_1093_eurheartj_ehx295 crossref_primary_10_1016_j_carrev_2021_11_010 crossref_primary_10_4244_EIJV12I1A236 crossref_primary_10_4244_EIJV11SWA27 crossref_primary_10_1159_000452617 crossref_primary_10_1017_S0266462320000100 crossref_primary_10_1016_j_jacc_2015_05_046 crossref_primary_10_1007_s10554_016_0889_x crossref_primary_10_1007_s12265_024_10484_z crossref_primary_10_1136_openhrt_2016_000468 crossref_primary_10_1002_ccd_27934 crossref_primary_10_1016_j_jcin_2017_08_005 crossref_primary_10_2459_JCM_0000000000000252 crossref_primary_10_2459_JCM_0000000000000494 crossref_primary_10_1080_14728222_2022_2118576 crossref_primary_10_1253_circrep_CR_22_0035 crossref_primary_10_2217_fca_2020_0140 crossref_primary_10_1016_j_jtcvs_2019_11_139 crossref_primary_10_1016_j_jcin_2017_05_021 crossref_primary_10_1177_1753944715575970 crossref_primary_10_1007_s11886_018_1073_9 crossref_primary_10_1016_j_rec_2016_09_012 crossref_primary_10_1016_j_jcin_2014_07_022 crossref_primary_10_1186_s12872_019_1021_7 crossref_primary_10_1016_j_jcin_2016_11_002 crossref_primary_10_1016_j_thromres_2018_07_028 crossref_primary_10_1155_2022_9138403 crossref_primary_10_1002_ccd_25788 crossref_primary_10_1016_j_jcmg_2015_07_012 crossref_primary_10_3390_jcm10153447 crossref_primary_10_1007_s11886_019_1250_5 crossref_primary_10_1161_CIRCULATIONAHA_116_023551 crossref_primary_10_1016_j_ahj_2024_12_011 crossref_primary_10_1111_joic_12356 crossref_primary_10_1016_j_jscai_2024_101929 crossref_primary_10_1161_CIRCIMAGING_119_009608 crossref_primary_10_1053_j_semtcvs_2017_06_001 crossref_primary_10_1016_j_athoracsur_2016_11_061 crossref_primary_10_1161_CIRCRESAHA_116_307972 crossref_primary_10_1186_s12872_016_0466_1 crossref_primary_10_1016_j_jjcc_2016_11_002 crossref_primary_10_3390_jcdd7030036 crossref_primary_10_1016_j_amjcard_2015_01_546 crossref_primary_10_1016_j_recesp_2015_11_020 crossref_primary_10_1016_j_ahj_2016_10_017 crossref_primary_10_1089_jwh_2017_6760 crossref_primary_10_1002_ccd_26658 crossref_primary_10_1161_CIRCINTERVENTIONS_115_003282 crossref_primary_10_1080_14779072_2020_1839419 crossref_primary_10_1016_j_crmic_2025_100062 crossref_primary_10_1177_0218492320930842 crossref_primary_10_1001_jamacardio_2022_4627 crossref_primary_10_4236_wjcd_2021_115025 crossref_primary_10_1016_j_jjcc_2017_06_007 crossref_primary_10_1111_joic_12378 crossref_primary_10_1016_j_ahj_2014_07_017 crossref_primary_10_1016_j_jcin_2020_06_041 crossref_primary_10_1089_gg_2016_0004 crossref_primary_10_1080_17434440_2017_1338136 crossref_primary_10_1080_17434440_2019_1552132 crossref_primary_10_1016_j_amjcard_2018_08_006 crossref_primary_10_1016_j_jcmg_2018_04_010 crossref_primary_10_1097_JAT_0000000000000147 crossref_primary_10_1016_j_rccl_2019_02_012 crossref_primary_10_1007_s13239_018_0349_y crossref_primary_10_1586_17434440_2015_1075387 crossref_primary_10_1080_13696998_2017_1304944 crossref_primary_10_1136_bcr_2020_239003 crossref_primary_10_1016_j_jcin_2015_02_005 crossref_primary_10_1161_JAHA_122_026812 crossref_primary_10_1002_ccd_29941 crossref_primary_10_3390_jcm12247705 crossref_primary_10_1002_ccd_25573 crossref_primary_10_1016_j_jcin_2014_06_012 crossref_primary_10_2459_JCM_0000000000000757 crossref_primary_10_1177_1089253220921588 crossref_primary_10_1007_s00059_015_4328_x crossref_primary_10_1016_j_iccl_2021_07_001 crossref_primary_10_1016_j_ccl_2014_09_004 crossref_primary_10_1002_phar_2056 crossref_primary_10_1016_j_hrtlng_2024_05_003 crossref_primary_10_1016_j_carrev_2017_06_011 crossref_primary_10_1111_jocs_14336 crossref_primary_10_1002_ccd_26666 crossref_primary_10_1007_s11886_016_0772_3 crossref_primary_10_1161_JAHA_123_033601 crossref_primary_10_1016_j_hlc_2020_08_025 crossref_primary_10_1016_j_iccl_2014_09_008 crossref_primary_10_1016_j_iccl_2014_09_004 crossref_primary_10_1016_j_jcin_2016_11_025 crossref_primary_10_1016_j_iccl_2014_09_005 crossref_primary_10_1016_j_iccl_2014_09_001 crossref_primary_10_1016_j_jcin_2023_02_002 crossref_primary_10_1016_j_recesp_2016_06_026 crossref_primary_10_4103_ajm_ajm_134_19 crossref_primary_10_2459_JCM_0000000000000776 crossref_primary_10_1016_j_carrev_2017_05_003 crossref_primary_10_1016_j_amjcard_2019_01_049 crossref_primary_10_1016_j_jacc_2023_12_006 crossref_primary_10_3390_jcm10235534 crossref_primary_10_1056_NEJMoa1814052 crossref_primary_10_1007_s11883_018_0741_y crossref_primary_10_1016_j_recesp_2015_08_009 crossref_primary_10_1007_s00398_022_00496_9 crossref_primary_10_1016_j_jcmg_2016_02_028 crossref_primary_10_1016_j_amjcard_2016_05_051 crossref_primary_10_1097_CRD_0000000000000784 crossref_primary_10_4244_EIJV15I11A179 crossref_primary_10_1002_ccd_29506 crossref_primary_10_1016_j_ijcme_2015_05_023 crossref_primary_10_1016_j_amjcard_2018_06_037 crossref_primary_10_1038_s41569_019_0254_6 crossref_primary_10_1016_j_amjcard_2015_08_043 crossref_primary_10_1016_j_hjc_2017_03_008 crossref_primary_10_1016_j_jcin_2017_03_018 crossref_primary_10_1016_j_jtcvs_2021_04_075 crossref_primary_10_1016_j_acvd_2017_03_006 crossref_primary_10_1080_24748706_2020_1805534 crossref_primary_10_1016_j_cej_2020_128244 crossref_primary_10_1002_ccd_27314 crossref_primary_10_3390_jcm13237256 crossref_primary_10_1007_s00392_017_1120_3 crossref_primary_10_1002_ccd_26462 crossref_primary_10_1016_j_rcl_2020_02_005 crossref_primary_10_1080_24748706_2020_1765442 crossref_primary_10_1161_CIRCINTERVENTIONS_124_014018 crossref_primary_10_1111_joic_12512 crossref_primary_10_1093_eurheartj_ehu410 crossref_primary_10_3389_fcvm_2018_00046 crossref_primary_10_4244_EIJY15M08_02 crossref_primary_10_1016_j_iccl_2021_06_003 crossref_primary_10_1002_ccd_29733 crossref_primary_10_1016_j_jcmg_2015_05_010 crossref_primary_10_3389_fcvm_2018_00045 crossref_primary_10_1016_j_jacc_2016_04_057 crossref_primary_10_1056_NEJMoa1509233 crossref_primary_10_1080_14779072_2020_1778465 crossref_primary_10_1016_j_carrev_2019_08_008 crossref_primary_10_1016_j_ijcard_2016_10_010 crossref_primary_10_1093_icvts_ivx197 crossref_primary_10_1055_s_0039_1688483 crossref_primary_10_4244_EIJ_D_23_01020 crossref_primary_10_1016_j_shj_2024_100372 crossref_primary_10_1007_s11936_016_0482_6 crossref_primary_10_1586_14779072_2015_1096778 crossref_primary_10_1093_ejcts_ezaa254 crossref_primary_10_1002_ccd_27336 crossref_primary_10_1016_j_athoracsur_2020_08_010 crossref_primary_10_1016_j_jcin_2019_06_019 crossref_primary_10_1016_S1131_3587_15_30020_0 crossref_primary_10_1080_17434440_2017_1347038 crossref_primary_10_1007_s11886_024_02076_9 crossref_primary_10_1016_j_amjcard_2024_07_026 crossref_primary_10_1161_CIRCULATIONAHA_122_062481 crossref_primary_10_1016_j_jcin_2019_07_048 crossref_primary_10_1080_17434440_2020_1732812 crossref_primary_10_1016_j_tcm_2014_10_001 crossref_primary_10_1016_j_jacadv_2024_100841 crossref_primary_10_1016_j_jcin_2019_08_035 crossref_primary_10_1161_CIRCINTERVENTIONS_117_005206 crossref_primary_10_1016_j_jcin_2022_10_020 crossref_primary_10_1056_NEJMoa1816885 crossref_primary_10_14797_mdcj_12_1_33 crossref_primary_10_1093_eurheartj_ehz925 crossref_primary_10_1093_ehjimp_qyae040 crossref_primary_10_17116_kardio202316051498 crossref_primary_10_4244_EIJV11I10A253 crossref_primary_10_1007_s11883_020_0835_1 crossref_primary_10_1016_j_echo_2017_10_022 crossref_primary_10_1007_s12471_021_01568_5 crossref_primary_10_1016_j_jacc_2016_07_762 crossref_primary_10_1016_j_jsha_2018_07_002 crossref_primary_10_1161_CIRCINTERVENTIONS_114_001410 crossref_primary_10_1002_ccd_30760 crossref_primary_10_1161_JAHA_120_015921 crossref_primary_10_1016_j_jtcvs_2016_11_069 crossref_primary_10_1016_j_jcmg_2014_12_014 crossref_primary_10_1002_ccd_30764 crossref_primary_10_1016_j_hlc_2017_02_032 crossref_primary_10_1016_j_jacc_2015_06_1346 crossref_primary_10_1007_s00246_021_02541_0 crossref_primary_10_1093_eurheartj_sux012 crossref_primary_10_1016_j_jacc_2018_03_459 crossref_primary_10_1136_openhrt_2023_002265 crossref_primary_10_1016_j_jcin_2024_12_016 crossref_primary_10_1136_heartjnl_2014_307332 crossref_primary_10_1536_ihj_19_395 crossref_primary_10_1016_j_shj_2024_100327 crossref_primary_10_4244_EIJ_D_17_00252 crossref_primary_10_1080_24748706_2021_1883782 crossref_primary_10_1016_j_jcin_2014_07_007 crossref_primary_10_1038_nrcardio_2017_82 crossref_primary_10_7861_clinmedicine_15_5_420 crossref_primary_10_1016_j_jtcvs_2017_12_150 crossref_primary_10_1007_s40258_014_0141_6 crossref_primary_10_12688_f1000research_6446_1 crossref_primary_10_1016_j_jtcvs_2016_12_075 crossref_primary_10_1016_j_ijcha_2021_100817 crossref_primary_10_1080_00365513_2024_2338742 crossref_primary_10_1111_anec_12734 crossref_primary_10_1002_hsr2_1391 crossref_primary_10_1016_j_jcin_2014_08_016 crossref_primary_10_1056_NEJMoa1514616 crossref_primary_10_1002_ccd_27377 crossref_primary_10_1016_j_carrev_2021_01_025 crossref_primary_10_1161_JAHA_115_002712 crossref_primary_10_1007_s10554_025_03333_w crossref_primary_10_1016_j_cpsurg_2022_101246 crossref_primary_10_1056_NEJMc1908500 crossref_primary_10_11622_smedj_2016115 crossref_primary_10_1213_ANE_0000000000007087 crossref_primary_10_1016_j_amjcard_2016_02_021 crossref_primary_10_1007_s11886_019_1234_5 crossref_primary_10_1016_j_tcm_2014_11_004 crossref_primary_10_1016_j_jcin_2019_07_008 crossref_primary_10_1016_j_recesp_2017_11_018 crossref_primary_10_1007_s00392_022_02006_1 crossref_primary_10_1016_j_jtcvs_2017_11_108 crossref_primary_10_1016_j_athoracsur_2016_02_106 crossref_primary_10_1016_j_ijcard_2023_131196 crossref_primary_10_1007_s11883_015_0488_7 crossref_primary_10_7759_cureus_53661 crossref_primary_10_1016_j_amjcard_2023_07_137 crossref_primary_10_1093_eurheartj_ehx785 crossref_primary_10_1002_ccd_31420 crossref_primary_10_1016_j_athoracsur_2020_01_074 crossref_primary_10_1093_cvr_cvz098 crossref_primary_10_1161_CIRCULATIONAHA_114_008144 crossref_primary_10_1016_j_athoracsur_2017_01_064 crossref_primary_10_1016_j_jmbbm_2019_103559 crossref_primary_10_1093_ehjci_jev128 crossref_primary_10_1016_j_carrev_2023_01_022 crossref_primary_10_1016_j_carrev_2014_05_002 crossref_primary_10_1016_j_jacc_2019_06_012 crossref_primary_10_1007_s00392_019_01571_2 crossref_primary_10_1007_s12471_020_01526_7 crossref_primary_10_3389_fcvm_2020_608158 crossref_primary_10_1016_j_ahj_2017_08_006 crossref_primary_10_1016_j_jtcvs_2021_04_002 crossref_primary_10_1016_j_ijcha_2019_100346 crossref_primary_10_1016_j_carrev_2020_11_007 crossref_primary_10_1016_j_amjmed_2017_05_031 crossref_primary_10_1093_eurheartj_ehu257 crossref_primary_10_1016_j_shj_2023_100167 crossref_primary_10_1007_s10554_017_1155_6 crossref_primary_10_1002_ccd_28279 crossref_primary_10_1093_icvts_ivw142 crossref_primary_10_1016_j_iccl_2021_05_004 crossref_primary_10_1016_j_jtcvs_2015_07_050 crossref_primary_10_62347_PORE5631 crossref_primary_10_15420_usc_2017_25_2 crossref_primary_10_1016_j_shj_2023_100179 crossref_primary_10_1155_2023_5563121 crossref_primary_10_1136_openhrt_2019_001064 crossref_primary_10_1016_j_amjcard_2019_06_026 crossref_primary_10_1016_j_jacc_2020_11_035 crossref_primary_10_4244_EIJV10SUA3 crossref_primary_10_4244_EIJV10SUA5 crossref_primary_10_1016_j_acvd_2019_10_006 crossref_primary_10_1016_j_acvd_2016_12_008 crossref_primary_10_1016_j_rec_2015_11_018 crossref_primary_10_1016_j_jacc_2014_05_067 crossref_primary_10_1093_ageing_afaa071 crossref_primary_10_1016_j_amcp_2022_03_012 crossref_primary_10_1161_CIRCINTERVENTIONS_115_003426 crossref_primary_10_1161_CIR_0000000000000503 crossref_primary_10_1007_s00059_016_4444_2 crossref_primary_10_1007_s00059_017_4632_8 crossref_primary_10_1161_CIRCINTERVENTIONS_115_003665 crossref_primary_10_1093_eurheartj_ehy436 crossref_primary_10_1161_CIRCIMAGING_119_009014 crossref_primary_10_1016_j_jcin_2020_01_223 crossref_primary_10_1016_j_tcm_2017_08_004 crossref_primary_10_1016_j_jtcvs_2015_07_078 crossref_primary_10_1002_hep4_2094 crossref_primary_10_1253_circj_CJ_17_0672 crossref_primary_10_1377_hlthaff_2014_1010 crossref_primary_10_1016_j_jacc_2014_12_022 crossref_primary_10_1016_j_jacc_2019_06_058 crossref_primary_10_1016_j_jacc_2020_11_018 crossref_primary_10_17116_Cardiobulletin20231804119 crossref_primary_10_1016_j_ccl_2024_03_001 crossref_primary_10_4244_EIJ_D_18_00552 crossref_primary_10_1016_j_jcin_2019_12_026 crossref_primary_10_1016_j_recesp_2017_10_041 crossref_primary_10_1098_rsif_2021_0599 crossref_primary_10_1016_j_amjcard_2016_08_013 crossref_primary_10_1016_j_hjc_2019_10_016 crossref_primary_10_1016_j_cger_2016_01_006 crossref_primary_10_3390_diagnostics13030427 crossref_primary_10_1016_j_iccl_2018_06_004 crossref_primary_10_1016_j_iccl_2018_06_005 crossref_primary_10_1016_j_iccl_2018_06_002 crossref_primary_10_1016_j_ijcha_2016_06_002 crossref_primary_10_1016_j_pcad_2021_11_003 crossref_primary_10_3390_jcm9082421 crossref_primary_10_1007_s11886_020_01344_8 crossref_primary_10_1161_CIRCULATIONAHA_118_035236 crossref_primary_10_36660_abc_20201047 crossref_primary_10_1016_j_amjcard_2020_01_002 crossref_primary_10_23736_S2724_5683_24_06477_9 crossref_primary_10_1016_j_jacadv_2024_100912 crossref_primary_10_2176_nmc_oa_2021_0005 crossref_primary_10_1016_j_jtcvs_2017_03_118 crossref_primary_10_4244_EIJ_D_16_00677 crossref_primary_10_1161_CIRCINTERVENTIONS_118_007411 crossref_primary_10_1016_j_jcmg_2016_06_002 crossref_primary_10_1111_jgs_14776 crossref_primary_10_1016_j_amjcard_2016_09_030 crossref_primary_10_1016_j_jcin_2020_02_033 crossref_primary_10_1007_s12928_022_00900_z crossref_primary_10_1007_s10840_020_00902_y crossref_primary_10_1016_j_jcmg_2018_07_028 crossref_primary_10_1097_HCO_0000000000001161 crossref_primary_10_15212_CVIA_2016_0012 crossref_primary_10_1016_j_jtcvs_2018_04_058 crossref_primary_10_1016_j_athoracsur_2020_10_030 crossref_primary_10_1016_j_jacc_2014_11_026 crossref_primary_10_1016_j_acvd_2019_03_003 crossref_primary_10_1016_j_recesp_2016_06_005 crossref_primary_10_1002_ccd_25823 crossref_primary_10_1093_eurheartj_ehx390 crossref_primary_10_1080_24748706_2018_1500049 crossref_primary_10_1093_eurheartj_ehv191 crossref_primary_10_1016_j_amjcard_2020_12_032 crossref_primary_10_1007_s13239_022_00647_x crossref_primary_10_1097_CRD_0000000000000043 crossref_primary_10_1001_jamacardio_2018_3562 crossref_primary_10_1016_j_jcin_2020_03_046 crossref_primary_10_1016_j_jcin_2020_03_049 crossref_primary_10_1007_s11936_018_0642_y crossref_primary_10_1016_S2666_7568_22_00168_4 crossref_primary_10_1016_j_carrev_2022_05_011 crossref_primary_10_1016_j_jacc_2015_10_046 crossref_primary_10_1016_j_mcna_2015_02_009 crossref_primary_10_1136_heartjnl_2023_322946 crossref_primary_10_1016_j_ijcard_2017_05_074 crossref_primary_10_1080_24748706_2019_1686556 crossref_primary_10_1016_j_ijmedinf_2021_104466 crossref_primary_10_1097_JCMA_0000000000000187 crossref_primary_10_1016_j_anrea_2019_10_001 crossref_primary_10_1053_j_jvca_2022_04_009 crossref_primary_10_3934_medsci_2015_1_51 crossref_primary_10_21693_1933_088X_14_2_95 crossref_primary_10_1111_pace_13412 crossref_primary_10_1016_j_ahjo_2024_100485 crossref_primary_10_3390_jcdd8090114 crossref_primary_10_1136_heartjnl_2018_314313 crossref_primary_10_1007_s00059_020_04976_2 crossref_primary_10_1016_j_jcin_2024_09_003 crossref_primary_10_1161_JAHA_120_017487 crossref_primary_10_1016_j_amjcard_2016_05_013 crossref_primary_10_1016_j_hjc_2019_03_009 crossref_primary_10_1053_j_semtcvs_2018_10_005 crossref_primary_10_1002_ccd_25831 crossref_primary_10_1016_j_jcin_2014_04_004 crossref_primary_10_1016_j_athoracsur_2019_10_060 crossref_primary_10_1016_j_athoracsur_2019_05_035 crossref_primary_10_1016_j_jacc_2016_06_042 crossref_primary_10_1016_j_amjcard_2022_12_002 crossref_primary_10_1016_j_iccl_2015_08_011 crossref_primary_10_1016_j_amjcard_2023_08_140 crossref_primary_10_1016_j_jcin_2017_01_045 crossref_primary_10_1007_s12410_016_9376_y crossref_primary_10_1371_journal_pone_0251066 crossref_primary_10_1016_j_jacc_2018_09_014 crossref_primary_10_1002_ccd_27805 crossref_primary_10_1002_ccd_25866 crossref_primary_10_1016_j_jcin_2020_10_031 crossref_primary_10_1016_j_repce_2017_06_002 crossref_primary_10_1016_j_echo_2015_11_002 crossref_primary_10_1016_j_amjcard_2023_07_109 crossref_primary_10_1093_ehjcr_yty112 crossref_primary_10_1177_15569845211041360 crossref_primary_10_1002_ccd_27820 crossref_primary_10_4244_EIJ_D_22_00958 crossref_primary_10_1016_j_jcin_2016_08_050 crossref_primary_10_3390_jcm10143102 crossref_primary_10_1016_j_mayocp_2024_11_001 crossref_primary_10_1002_ccd_31088 crossref_primary_10_1186_s12872_023_03584_2 crossref_primary_10_1186_s13019_021_01689_3 crossref_primary_10_1016_j_jtcvs_2015_06_008 crossref_primary_10_1002_ccd_27829 crossref_primary_10_1253_circj_CJ_18_0264 crossref_primary_10_1055_s_0041_1736206 crossref_primary_10_1053_j_jvca_2017_04_004 crossref_primary_10_1016_j_jacc_2018_01_057 crossref_primary_10_4244_EIJV11I9A212 crossref_primary_10_1161_CIRCULATIONAHA_119_043785 crossref_primary_10_1016_j_jcin_2020_04_028 crossref_primary_10_3390_jcdd10090386 crossref_primary_10_1161_CIRCULATIONAHA_114_012815 crossref_primary_10_1016_j_repc_2022_09_004 crossref_primary_10_1016_j_athoracsur_2014_06_087 crossref_primary_10_1016_j_jacc_2020_05_085 crossref_primary_10_1016_j_jacc_2018_09_004 crossref_primary_10_1016_j_amjcard_2019_03_043 crossref_primary_10_1016_j_jjcc_2019_02_022 crossref_primary_10_1111_jocs_13574 crossref_primary_10_3390_jcm11030499 crossref_primary_10_1186_s12933_024_02414_9 crossref_primary_10_1016_j_athoracsur_2016_02_020 crossref_primary_10_1016_j_carrev_2016_05_010 crossref_primary_10_1007_s12574_019_00448_7 crossref_primary_10_1016_j_jcin_2019_10_043 crossref_primary_10_1016_j_jcin_2018_07_023 crossref_primary_10_31083_j_rcm2309290 crossref_primary_10_1016_j_jtcvs_2016_06_063 crossref_primary_10_1016_j_jtcvs_2016_05_023 crossref_primary_10_1111_jocs_15513 crossref_primary_10_1002_ccd_27602 crossref_primary_10_1016_j_pcad_2021_06_004 crossref_primary_10_1016_j_amjcard_2018_01_049 crossref_primary_10_4244_EIJ_D_18_01048 crossref_primary_10_1016_j_athoracsur_2015_08_032 crossref_primary_10_1016_j_ijcard_2017_05_120 crossref_primary_10_1016_j_amjcard_2016_12_016 crossref_primary_10_1016_j_jcin_2015_09_027 crossref_primary_10_1016_j_jcin_2016_03_024 crossref_primary_10_1016_j_jacc_2015_11_013 crossref_primary_10_1016_j_jacc_2018_10_083 crossref_primary_10_1016_j_ahj_2023_10_002 crossref_primary_10_1016_j_jacc_2015_12_059 crossref_primary_10_1016_j_jacc_2019_03_496 crossref_primary_10_1161_CIRCULATIONAHA_116_022797 crossref_primary_10_1016_j_jcin_2015_10_025 crossref_primary_10_1016_j_jcin_2015_10_024 crossref_primary_10_1213_XAA_0000000000000311 crossref_primary_10_1093_eurheartj_ehac642 crossref_primary_10_1038_nrcardio_2014_137 crossref_primary_10_1007_s11886_020_01425_8 crossref_primary_10_1016_j_jcin_2019_02_029 crossref_primary_10_1111_joic_12248 crossref_primary_10_1007_s10840_020_00813_y crossref_primary_10_1016_j_jacc_2015_11_008 crossref_primary_10_1016_j_jcin_2015_08_015 crossref_primary_10_1007_s10840_018_0345_z crossref_primary_10_1016_j_carrev_2024_07_013 crossref_primary_10_1080_24748706_2018_1440097 crossref_primary_10_1016_j_jcct_2019_12_001 crossref_primary_10_1016_j_jcin_2015_08_017 crossref_primary_10_1038_nrcardio_2014_136 crossref_primary_10_1001_jama_2021_2133 crossref_primary_10_1056_NEJMoa2204961 crossref_primary_10_1007_s10439_023_03419_3 crossref_primary_10_1016_S0140_6736_17_30757_2 crossref_primary_10_1002_ehf2_13876 crossref_primary_10_1080_14779072_2019_1598264 crossref_primary_10_3390_jcm14061844 crossref_primary_10_1016_j_jcin_2018_07_032 crossref_primary_10_1016_j_hjc_2017_09_013 crossref_primary_10_1016_j_jacc_2017_06_045 crossref_primary_10_1016_j_hfc_2017_02_009 crossref_primary_10_1056_NEJMoa1700456 crossref_primary_10_1136_heartjnl_2017_311738 crossref_primary_10_1016_j_jcin_2017_12_017 crossref_primary_10_1136_tsaco_2018_000218 crossref_primary_10_1007_s00595_020_01977_w crossref_primary_10_1556_650_2022_32333 crossref_primary_10_1161_CIRCINTERVENTIONS_117_005727 crossref_primary_10_1160_TH16_06_0487 crossref_primary_10_1016_j_tcm_2023_04_004 crossref_primary_10_1093_eurheartj_ehu502 crossref_primary_10_2217_fca_15_2 crossref_primary_10_1161_JAHA_116_004203 crossref_primary_10_1007_s10439_018_02129_5 crossref_primary_10_1016_j_jacc_2017_06_056 crossref_primary_10_32892_jmri_180 crossref_primary_10_1016_j_jcin_2015_08_022 crossref_primary_10_1016_j_rec_2017_11_024 crossref_primary_10_1080_24748706_2019_1630787 crossref_primary_10_1007_s11886_017_0850_1 crossref_primary_10_1016_j_ijcard_2018_10_093 crossref_primary_10_1007_s12603_020_1375_7 crossref_primary_10_1016_j_jscai_2022_100562 crossref_primary_10_1053_j_jvca_2019_11_001 crossref_primary_10_1097_TGR_0000000000000318 crossref_primary_10_1016_j_ijcard_2016_04_023 crossref_primary_10_1002_ccd_28512 crossref_primary_10_1016_j_jcin_2022_01_284 crossref_primary_10_1080_24748706_2018_1522460 crossref_primary_10_1007_s11886_015_0694_5 crossref_primary_10_1016_j_cjca_2022_06_005 crossref_primary_10_1016_j_jtcvs_2024_06_023 crossref_primary_10_1016_j_amjcard_2020_06_033 crossref_primary_10_1016_j_amjcard_2017_07_059 crossref_primary_10_1161_CIRCINTERVENTIONS_122_012623 crossref_primary_10_1002_ccd_29841 crossref_primary_10_1002_ccd_26336 crossref_primary_10_1002_ccd_28999 crossref_primary_10_1002_ccd_26564 crossref_primary_10_1002_ccd_28741 crossref_primary_10_1002_ccd_26562 crossref_primary_10_1007_s00392_023_02181_9 crossref_primary_10_1016_j_echo_2017_02_002 crossref_primary_10_1016_j_amjcard_2020_06_020 crossref_primary_10_1016_j_jcin_2015_10_050 crossref_primary_10_1016_j_jtcvs_2015_11_022 crossref_primary_10_1016_j_amjcard_2017_07_063 crossref_primary_10_1007_s11936_018_0648_5 crossref_primary_10_1259_bjr_20230296 crossref_primary_10_1111_joic_12291 crossref_primary_10_36660_abc_20190772 crossref_primary_10_1111_jocs_15355 crossref_primary_10_2459_JCM_0000000000000829 crossref_primary_10_1053_j_semtcvs_2016_06_008 crossref_primary_10_1186_s12872_023_03063_8 crossref_primary_10_1016_j_carrev_2018_03_014 crossref_primary_10_1016_j_rec_2017_10_029 crossref_primary_10_1161_CIRCINTERVENTIONS_123_013578 crossref_primary_10_4244_EIJ_D_19_00587 crossref_primary_10_1002_ccd_30845 crossref_primary_10_1093_eurheartj_ehab368 crossref_primary_10_1016_j_jcin_2023_12_005 crossref_primary_10_1002_ccd_28520 crossref_primary_10_1016_j_jacc_2023_02_017 crossref_primary_10_1016_j_athoracsur_2016_04_038 crossref_primary_10_1016_j_jcin_2021_08_006 crossref_primary_10_3109_13645706_2015_1047852 crossref_primary_10_1002_ccd_26347 crossref_primary_10_3390_jcm11195588 crossref_primary_10_1016_j_jcin_2018_05_042 crossref_primary_10_1161_CIRCULATIONAHA_115_020493 crossref_primary_10_1161_CIR_0000000000000923 crossref_primary_10_4244_EIJ_D_18_00343 crossref_primary_10_1155_2019_1906814 crossref_primary_10_1093_eurheartj_ehac242 crossref_primary_10_1186_s12933_024_02160_y crossref_primary_10_3390_jcm12227126 crossref_primary_10_1007_s15027_014_0439_1 crossref_primary_10_1097_HCO_0000000000000609 crossref_primary_10_4244_EIJV12I4A84 crossref_primary_10_1161_CIRCINTERVENTIONS_115_002909 crossref_primary_10_1016_j_carrev_2015_08_011 crossref_primary_10_1016_j_amjcard_2015_01_022 crossref_primary_10_1080_24748706_2019_1694730 crossref_primary_10_1016_j_jacc_2018_08_1033 crossref_primary_10_1111_jocs_13187 crossref_primary_10_1155_2017_9027597 crossref_primary_10_1161_CIR_0000000000000932 crossref_primary_10_1016_j_anclin_2015_05_006 crossref_primary_10_1016_j_mayocp_2023_09_024 crossref_primary_10_33290_jtvt_ra_20_2005 crossref_primary_10_1111_aor_12806 crossref_primary_10_3390_jcm10163529 crossref_primary_10_1080_24748706_2019_1619957 crossref_primary_10_1097_imi_0000000000000504 crossref_primary_10_1016_j_jcin_2017_11_013 crossref_primary_10_1016_j_rec_2015_08_010 crossref_primary_10_1002_ccd_29429 crossref_primary_10_4244_EIJV12I6A125 crossref_primary_10_1007_s00398_015_0018_5 crossref_primary_10_4244_EIJV12I6A126 crossref_primary_10_5694_mja17_01255 crossref_primary_10_1093_icvts_ivy189 crossref_primary_10_1016_j_carrev_2016_02_003 crossref_primary_10_1016_j_jcin_2021_09_019 crossref_primary_10_1016_j_ijcard_2020_05_065 crossref_primary_10_1016_j_accpm_2019_06_009 crossref_primary_10_1161_CIRCULATIONAHA_117_028352 crossref_primary_10_1016_j_amjcard_2021_01_021 crossref_primary_10_1016_j_jacc_2014_08_042 crossref_primary_10_1016_j_jacc_2018_08_2146 crossref_primary_10_1016_j_jcin_2016_02_005 crossref_primary_10_1016_j_rec_2015_08_019 crossref_primary_10_1161_CIRCINTERVENTIONS_121_010543 crossref_primary_10_1016_j_shj_2022_100077 crossref_primary_10_4244_EIJ_D_20_00279 crossref_primary_10_1016_j_hlc_2015_07_017 crossref_primary_10_1016_j_repc_2017_05_006 crossref_primary_10_1016_j_jacc_2023_04_049 crossref_primary_10_1002_ccd_27232 crossref_primary_10_1016_S1131_3587_15_30021_2 crossref_primary_10_1186_s12947_015_0040_5 crossref_primary_10_1016_j_athoracsur_2019_08_113 crossref_primary_10_1016_j_jcin_2018_07_050 crossref_primary_10_1161_CIRCINTERVENTIONS_120_010258 crossref_primary_10_1016_j_amjcard_2014_07_019 crossref_primary_10_1016_j_echo_2015_01_007 crossref_primary_10_1016_j_jjcc_2017_11_007 crossref_primary_10_3389_fmedt_2022_959249 crossref_primary_10_1093_eurheartj_suw017 crossref_primary_10_1007_s11936_017_0580_0 crossref_primary_10_1177_155698451801300306 crossref_primary_10_1161_CIRCOUTCOMES_118_005048 crossref_primary_10_1016_S0140_6736_16_30073_3 crossref_primary_10_1002_clc_22328 crossref_primary_10_1016_j_amjcard_2019_07_010 crossref_primary_10_3389_fcvm_2018_00111 crossref_primary_10_1002_ccd_27257 crossref_primary_10_12688_f1000research_17995_1 crossref_primary_10_1007_s11886_021_01481_8 crossref_primary_10_1016_j_acvd_2022_03_001 crossref_primary_10_1016_j_cpcardiol_2024_102478 crossref_primary_10_1016_j_jtcvs_2015_10_070 crossref_primary_10_1111_joic_12458 crossref_primary_10_1016_j_carrev_2023_10_016 crossref_primary_10_1016_j_jcin_2017_10_014 crossref_primary_10_1161_CIRCINTERVENTIONS_120_009496 crossref_primary_10_1016_j_jacc_2017_03_011 crossref_primary_10_1586_17434440_2016_1149288 |
| Cites_doi | 10.1016/j.jacc.2011.11.045 10.1016/j.jtcvs.2008.12.030 10.1016/j.jacc.2012.08.1039 10.1016/j.jcin.2008.04.007 10.1093/eurheartj/ehi471 10.1016/j.jacc.2006.05.021 10.1093/eurheartj/ehr491 10.1016/j.amjcard.2004.08.061 10.1016/0021-9681(87)90171-8 10.1001/jama.2013.282043 10.1016/j.jacc.2010.11.044 10.1016/j.jacc.2010.12.005 10.1016/j.jacc.2010.06.039 10.1002/ccd.22355 10.1016/j.jacc.2012.03.054 10.1007/s00392-008-0650-0 10.1111/j.1540-8183.2006.00142.x 10.1056/NEJMoa1202277 10.1016/0022-3956(75)90026-6 10.1161/CIRCULATIONAHA.109.927152 10.4244/EIJ30V6I4A80 10.1016/S0140-6736(09)60211-7 10.1016/j.amjcard.2010.10.054 10.1056/NEJMoa1103510 10.1001/jama.1963.03060120024016 10.1056/NEJMoa1008232 10.1016/j.hlc.2008.06.002 10.1016/j.jacc.2013.02.087 10.1016/j.jacc.2012.01.001 10.1016/j.jacc.2013.01.047 10.1016/j.jacc.2011.05.007 10.1016/j.jacc.2012.02.022 10.1111/j.1540-8167.2011.02211.x 10.1016/j.jcin.2012.06.011 10.1016/S0195-668X(02)00799-6 10.1016/j.athoracsur.2009.05.056 10.4244/EIJV8I5A86 10.1016/j.jacc.2013.04.036 10.1519/00139143-200704000-00006 |
| ContentType | Journal Article |
| Contributor | George, Barry Franz, Douglas Kishimoto, Ikuko Blossom, Geoffrey Pershad, Ashish Kato, Naomi Sharma, Samin Schmidt, Wendy Adams, David H Harrison, J Kevin Loli, Akil Kreydi, Ghassan Page, Susie Terry, Tammy Duff, Steven Powell, Patrice Williamson, Danielle Watson, Daniel Reardon, Michael Wootton, Samantha Swisher, Christa Gallagher, Sara Brinegar, Pat Carl, Heidi O'Hair, Daniel Glower, Donald Popelas, Lori Karson, Jodi Waller, Deborah Jones, Shameka Munir, Ahmad Burkert, Lynn Coselli, Joseph Yang, Julian Engle, Chrissy Huang, Hong Bajwa, Tanvir Ball, Michael Fusilero, Michael Dabir, Reza Hermiller, James Aurakzai, Hamza Pierce, Cynthia Yakubov, Steven Werner, Paul Gall, Jill Hollabaugh, Jaime Stelzer, Paul Tkach, Alexsander Brady, Kevin Robb, Greta Allaqaband, Suhail Vavalle, J Hunter, Kitra Wiley, Mark Elsner, Gregory Gregoric, Igor Salerno, Christopher Diez, Jose Gilchrist, Julianne Cohn, William Kini, Annapoorna Paul, Bonnie Halim, Sharif Ramchandani, Mahesh Anyanwu, Anelechi Kafi, Ali Caskey, Michael Joseph, Jane Fang, Kenith Ott, David Green, LaShawna |
| Contributor_xml | – sequence: 1 givenname: Neal S surname: Kleiman fullname: Kleiman, Neal S – sequence: 2 givenname: Michael surname: Reardon fullname: Reardon, Michael – sequence: 3 givenname: Mahesh surname: Ramchandani fullname: Ramchandani, Mahesh – sequence: 4 givenname: Gerald surname: Lawrie fullname: Lawrie, Gerald – sequence: 5 givenname: Pat surname: Brinegar fullname: Brinegar, Pat – sequence: 6 givenname: Jeannie surname: Arredondo fullname: Arredondo, Jeannie – sequence: 7 givenname: Jane surname: Joseph fullname: Joseph, Jane – sequence: 8 givenname: LaShawna surname: Green fullname: Green, LaShawna – sequence: 9 givenname: James surname: Hermiller fullname: Hermiller, James – sequence: 10 givenname: David surname: Heimansohn fullname: Heimansohn, David – sequence: 11 givenname: Michael surname: Ball fullname: Ball, Michael – sequence: 12 givenname: Jack surname: Hall fullname: Hall, Jack – sequence: 13 givenname: Gregory surname: Elsner fullname: Elsner, Gregory – sequence: 14 givenname: Peter surname: Walts fullname: Walts, Peter – sequence: 15 givenname: Scott surname: Hanan fullname: Hanan, Scott – sequence: 16 givenname: Robert surname: Robison fullname: Robison, Robert – sequence: 17 givenname: Christopher surname: Salerno fullname: Salerno, Christopher – sequence: 18 givenname: Lynn surname: Burkert fullname: Burkert, Lynn – sequence: 19 givenname: Patrice surname: Powell fullname: Powell, Patrice – sequence: 20 givenname: Jill surname: Gall fullname: Gall, Jill – sequence: 21 givenname: Sara surname: Gallagher fullname: Gallagher, Sara – sequence: 22 givenname: J Kevin surname: Harrison fullname: Harrison, J Kevin – sequence: 23 givenname: G Chad surname: Hughes fullname: Hughes, G Chad – sequence: 24 givenname: Andrew surname: Wang fullname: Wang, Andrew – sequence: 25 givenname: Donald surname: Glower fullname: Glower, Donald – sequence: 26 givenname: J surname: Vavalle fullname: Vavalle, J – sequence: 27 givenname: Sharif surname: Halim fullname: Halim, Sharif – sequence: 28 givenname: Julian surname: Yang fullname: Yang, Julian – sequence: 29 givenname: Christa surname: Swisher fullname: Swisher, Christa – sequence: 30 givenname: Cynthia surname: Pierce fullname: Pierce, Cynthia – sequence: 31 givenname: Dahlia surname: Cowhig fullname: Cowhig, Dahlia – sequence: 32 givenname: Megan surname: Arthur fullname: Arthur, Megan – sequence: 33 givenname: Samantha surname: Wootton fullname: Wootton, Samantha – sequence: 34 givenname: Naomi surname: Kato fullname: Kato, Naomi – sequence: 35 givenname: Julianne surname: Gilchrist fullname: Gilchrist, Julianne – sequence: 36 givenname: Jose surname: Diez fullname: Diez, Jose – sequence: 37 givenname: Joseph surname: Coselli fullname: Coselli, Joseph – sequence: 38 givenname: David surname: Ott fullname: Ott, David – sequence: 39 givenname: Igor surname: Gregoric fullname: Gregoric, Igor – sequence: 40 givenname: William surname: Cohn fullname: Cohn, William – sequence: 41 givenname: Mehdi surname: Jafar fullname: Jafar, Mehdi – sequence: 42 givenname: Juliette surname: Dean fullname: Dean, Juliette – sequence: 43 givenname: Jennifer surname: Parenti fullname: Parenti, Jennifer – sequence: 44 givenname: Shameka surname: Jones fullname: Jones, Shameka – sequence: 45 givenname: Sara surname: Orsi fullname: Orsi, Sara – sequence: 46 givenname: Danielle surname: Williamson fullname: Williamson, Danielle – sequence: 47 givenname: Theodore surname: Schreiber fullname: Schreiber, Theodore – sequence: 48 givenname: Ali surname: Kafi fullname: Kafi, Ali – sequence: 49 givenname: Nishit surname: Choksi fullname: Choksi, Nishit – sequence: 50 givenname: Ahmad surname: Munir fullname: Munir, Ahmad – sequence: 51 givenname: Reza surname: Dabir fullname: Dabir, Reza – sequence: 52 givenname: Heidi surname: Carl fullname: Carl, Heidi – sequence: 53 givenname: Hong surname: Huang fullname: Huang, Hong – sequence: 54 givenname: Hamza surname: Aurakzai fullname: Aurakzai, Hamza – sequence: 55 givenname: Ghassan surname: Kreydi fullname: Kreydi, Ghassan – sequence: 56 givenname: Timothy surname: Byrne fullname: Byrne, Timothy – sequence: 57 givenname: Michael surname: Caskey fullname: Caskey, Michael – sequence: 58 givenname: Ashish surname: Pershad fullname: Pershad, Ashish – sequence: 59 givenname: Akil surname: Loli fullname: Loli, Akil – sequence: 60 givenname: Kevin surname: Brady fullname: Brady, Kevin – sequence: 61 givenname: Kenith surname: Fang fullname: Fang, Kenith – sequence: 62 givenname: Jeremy surname: Payne fullname: Payne, Jeremy – sequence: 63 givenname: Douglas surname: Franz fullname: Franz, Douglas – sequence: 64 givenname: Alexsander surname: Tkach fullname: Tkach, Alexsander – sequence: 65 givenname: Jaime surname: Hollabaugh fullname: Hollabaugh, Jaime – sequence: 66 givenname: Ikuko surname: Kishimoto fullname: Kishimoto, Ikuko – sequence: 67 givenname: Steven surname: Yakubov fullname: Yakubov, Steven – sequence: 68 givenname: Daniel surname: Watson fullname: Watson, Daniel – sequence: 69 givenname: N Howard surname: Kander fullname: Kander, N Howard – sequence: 70 givenname: Geoffrey surname: Blossom fullname: Blossom, Geoffrey – sequence: 71 givenname: Steven surname: Duff fullname: Duff, Steven – sequence: 72 givenname: Barry surname: George fullname: George, Barry – sequence: 73 givenname: Greta surname: Robb fullname: Robb, Greta – sequence: 74 givenname: Lori surname: Popelas fullname: Popelas, Lori – sequence: 75 givenname: Kitra surname: Hunter fullname: Hunter, Kitra – sequence: 76 givenname: Chrissy surname: Engle fullname: Engle, Chrissy – sequence: 77 givenname: Tammy surname: Terry fullname: Terry, Tammy – sequence: 78 givenname: Bonnie surname: Paul fullname: Paul, Bonnie – sequence: 79 givenname: Christie surname: Hartley fullname: Hartley, Christie – sequence: 80 givenname: Peter surname: Tadros fullname: Tadros, Peter – sequence: 81 givenname: George surname: Zorn fullname: Zorn, George – sequence: 82 givenname: Mark surname: Wiley fullname: Wiley, Mark – sequence: 83 givenname: Gregory surname: Muehlebach fullname: Muehlebach, Gregory – sequence: 84 givenname: Susie surname: Page fullname: Page, Susie – sequence: 85 givenname: Jodi surname: Karson fullname: Karson, Jodi – sequence: 86 givenname: Samin surname: Sharma fullname: Sharma, Samin – sequence: 87 givenname: David H surname: Adams fullname: Adams, David H – sequence: 88 givenname: Annapoorna surname: Kini fullname: Kini, Annapoorna – sequence: 89 givenname: George surname: Dangas fullname: Dangas, George – sequence: 90 givenname: Anelechi surname: Anyanwu fullname: Anyanwu, Anelechi – sequence: 91 givenname: Paul surname: Stelzer fullname: Stelzer, Paul – sequence: 92 givenname: Michael surname: Fusilero fullname: Fusilero, Michael – sequence: 93 givenname: Arjun surname: Bhat fullname: Bhat, Arjun – sequence: 94 givenname: Kameswari surname: Vallabhajosyula fullname: Vallabhajosyula, Kameswari – sequence: 95 givenname: Tanvir surname: Bajwa fullname: Bajwa, Tanvir – sequence: 96 givenname: Daniel surname: O'Hair fullname: O'Hair, Daniel – sequence: 97 givenname: Suhail surname: Allaqaband fullname: Allaqaband, Suhail – sequence: 98 givenname: Paul surname: Werner fullname: Werner, Paul – sequence: 99 givenname: Wendy surname: Schmidt fullname: Schmidt, Wendy – sequence: 100 givenname: Deborah surname: Waller fullname: Waller, Deborah |
| Copyright | 2014 American College of Cardiology Foundation American College of Cardiology Foundation 2015 INIST-CNRS Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Limited May 20, 2014 |
| Copyright_xml | – notice: 2014 American College of Cardiology Foundation – notice: American College of Cardiology Foundation – notice: 2015 INIST-CNRS – notice: Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited May 20, 2014 |
| CorporateAuthor | CoreValve United States Clinical Investigators |
| CorporateAuthor_xml | – name: CoreValve United States Clinical Investigators |
| DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 |
| DOI | 10.1016/j.jacc.2014.02.556 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1558-3597 |
| EndPage | 1981 |
| ExternalDocumentID | 3301392941 24657695 28548586 10_1016_j_jacc_2014_02_556 S0735109714013965 1_s2_0_S0735109714013965 |
| Genre | Clinical Trial Multicenter Study Journal Article |
| GrantInformation_xml | – fundername: Medtronic, Inc – fundername: Medtronic – fundername: Boston Scientific – fundername: Abiomed – fundername: Cordis – fundername: eV3 – fundername: Edwards Lifesciences – fundername: CoreValve – fundername: Covidien – fundername: Abbott Vascular |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AAEDT AAEDW AAIKJ AAOAW AAQFI AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ACVFH ADBBV ADCNI ADEZE ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRAH AFRHN AFTJW AGCQF AGHFR AGYEJ AHMBA AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CS3 DIK DU5 E3Z EBS EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF IHE IXB J1W K-O KQ8 L7B MO0 N9A O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R .55 .GJ 0SF 1CY 29L 3O- 3V. 6I. 7RV AACTN AAFTH AAKUH AALRI AAQQT AAQXK AAYOK ABVKL ABWVN ACRPL ADMUD ADNMO AFCTW AFETI AFFNX AJOXV AMFUW ASPBG AVWKF AZFZN BENPR BPHCQ FGOYB HX~ HZ~ J5H N4W NCXOZ QTD R2- RIG SEW T5K X7M XPP YYP ZGI ZXP AAIAV ABJNI EFLBG LCYCR NAHTW ZA5 AAYWO AAYXX AGQPQ CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c520t-e88b87af1418fd18796e6aabbebdee62b77cfe2fb6f0136d1fca4fcbec54d8553 |
| IEDL.DBID | IXB |
| ISSN | 0735-1097 1558-3597 |
| IngestDate | Fri Jul 11 16:55:26 EDT 2025 Sat Jul 26 03:03:53 EDT 2025 Thu Apr 03 07:09:10 EDT 2025 Wed Apr 02 07:16:10 EDT 2025 Thu Apr 24 23:11:45 EDT 2025 Tue Jul 01 01:32:12 EDT 2025 Fri Feb 23 02:32:16 EST 2024 Sun Feb 23 10:18:56 EST 2025 Tue Aug 26 18:31:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 19 |
| Keywords | NYHA aortic stenosis THV VARC outcomes STS-PROM OPG transcatheter aortic valve replacement EuroSCORE MACCE SAVR TAVR European System for Cardiac Operative Risk Evaluation objective performance goal transcatheter heart valve Valve Academic Research Consortium major adverse cardiovascular and cerebral event(s) New York Heart Association Society for Thoracic Surgery Predicted Risk of Mortality surgical aortic valve replacement Human Aortic stenosis Prosthesis Bioprosthesis Patient Cardiovascular disease Self Heart valve Treatment Expanding Surgery Circulatory system Cardiology Severe Aortic valve |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c520t-e88b87af1418fd18796e6aabbebdee62b77cfe2fb6f0136d1fca4fcbec54d8553 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0735109714013965 |
| PMID | 24657695 |
| PQID | 1523894151 |
| PQPubID | 2031078 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1525763400 proquest_journals_1523894151 pubmed_primary_24657695 pascalfrancis_primary_28548586 crossref_primary_10_1016_j_jacc_2014_02_556 crossref_citationtrail_10_1016_j_jacc_2014_02_556 elsevier_sciencedirect_doi_10_1016_j_jacc_2014_02_556 elsevier_clinicalkeyesjournals_1_s2_0_S0735109714013965 elsevier_clinicalkey_doi_10_1016_j_jacc_2014_02_556 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-05-20 |
| PublicationDateYYYYMMDD | 2014-05-20 |
| PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
| PublicationTitle | Journal of the American College of Cardiology |
| PublicationTitleAlternate | J Am Coll Cardiol |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
| References | Yamen, Daniels, Van, Yeung, Fearon (bib23) 2010; 75 Piazza, Onuma, Jesserun (bib34) 2008; 1 Charlson, Pompei, Ales, MacKenzie (bib11) 1987; 40 Green, Woglom, Genereux (bib26) 2012; 5 Katz, Ford, Moskowitz, Jackson, Jaffe (bib14) 1963; 185 O'Brien, Shahian, Filardo (bib10) 2009; 88 Holmes, Mack, Kaul (bib25) 2012; 59 Sack, Kahlert, Khandanpour (bib20) 2008; 97 Kapadia, Goel, Svensson (bib22) 2009; 137 Khawaja, Rajani, Cook (bib37) 2011; 123 Makkar, Fontana, Jilaihawi (bib6) 2012; 366 Genereux, Head, Van Mieghem (bib5) 2012; 59 Carabello, Paulus (bib1) 2009; 373 Mack, Brennan, Brindis (bib28) 2013; 310 Buellesfeld, Stortecky, Heg (bib38) 2012; 60 Buellesfeld, Gerckens, Schuler (bib8) 2011; 57 Jilaihawi, Kashif, Fontana (bib33) 2012; 59 Fraccaro, Buja, Tarantini (bib35) 2011; 107 Agarwal, Kini, Attanti (bib17) 2005; 95 Holmes, Mack (bib24) 2011; 58 Leon, Piazza, Nikolsky (bib16) 2011; 57 Leon, Smith, Mack (bib4) 2010; 363 Piazza, Nuis, Tzikas (bib39) 2010; 6 Afilalo, Eisenberg, Morin (bib12) 2010; 56 Folstein, Folstein, McHugh (bib15) 1975; 12 To, Zeng, Coverdale (bib21) 2008; 17 Klein, Lee, Gera, Ports, Michaels (bib18) 2006; 19 Binder, Webb, Willson (bib32) 2013; 62 Erkapic De Rosa, Kelava, Lehmann, Fichtlscherer, Hohnloser (bib36) 2012; 23 Bonow, Carabello, Chatterjee (bib2) 2006; 48 Iung, Cachier, Baron (bib3) 2005; 26 Smith, Leon, Mack (bib7) 2011; 364 Ussia, Barbanti, Petronio (bib9) 2012; 33 Bohannon, Bear-Lehman, Desrosiers, Massy-Westropp, Mathiowetz (bib13) 2007; 30 Roques, Michel, Goldstone, Nashef (bib27) 2003; 24 Athappan, Patvardhan, Tuzcu (bib31) 2013; 61 Shareghi, Rasouli, Shavelle, Burstein, Matthews (bib19) 2007; 19 Tchetche, Modine, Farah (bib40) 2012; 8 Genereux, Head, Hahn (bib30) 2013; 61 Hahn, Pibarot, Stewart (bib29) 2013; 61 Bonow (10.1016/j.jacc.2014.02.556_bib2) 2006; 48 Yamen (10.1016/j.jacc.2014.02.556_bib23) 2010; 75 Leon (10.1016/j.jacc.2014.02.556_bib4) 2010; 363 Mack (10.1016/j.jacc.2014.02.556_bib28) 2013; 310 Tchetche (10.1016/j.jacc.2014.02.556_bib40) 2012; 8 Buellesfeld (10.1016/j.jacc.2014.02.556_bib8) 2011; 57 Leon (10.1016/j.jacc.2014.02.556_bib16) 2011; 57 Piazza (10.1016/j.jacc.2014.02.556_bib39) 2010; 6 Agarwal (10.1016/j.jacc.2014.02.556_bib17) 2005; 95 Genereux (10.1016/j.jacc.2014.02.556_bib30) 2013; 61 Roques (10.1016/j.jacc.2014.02.556_bib27) 2003; 24 Carabello (10.1016/j.jacc.2014.02.556_bib1) 2009; 373 Katz (10.1016/j.jacc.2014.02.556_bib14) 1963; 185 Iung (10.1016/j.jacc.2014.02.556_bib3) 2005; 26 Piazza (10.1016/j.jacc.2014.02.556_bib34) 2008; 1 Shareghi (10.1016/j.jacc.2014.02.556_bib19) 2007; 19 Makkar (10.1016/j.jacc.2014.02.556_bib6) 2012; 366 O'Brien (10.1016/j.jacc.2014.02.556_bib10) 2009; 88 Smith (10.1016/j.jacc.2014.02.556_bib7) 2011; 364 Green (10.1016/j.jacc.2014.02.556_bib26) 2012; 5 Athappan (10.1016/j.jacc.2014.02.556_bib31) 2013; 61 Erkapic De Rosa (10.1016/j.jacc.2014.02.556_bib36) 2012; 23 Afilalo (10.1016/j.jacc.2014.02.556_bib12) 2010; 56 Holmes (10.1016/j.jacc.2014.02.556_bib24) 2011; 58 To (10.1016/j.jacc.2014.02.556_bib21) 2008; 17 Fraccaro (10.1016/j.jacc.2014.02.556_bib35) 2011; 107 Holmes (10.1016/j.jacc.2014.02.556_bib25) 2012; 59 Jilaihawi (10.1016/j.jacc.2014.02.556_bib33) 2012; 59 Kapadia (10.1016/j.jacc.2014.02.556_bib22) 2009; 137 Buellesfeld (10.1016/j.jacc.2014.02.556_bib38) 2012; 60 Klein (10.1016/j.jacc.2014.02.556_bib18) 2006; 19 Khawaja (10.1016/j.jacc.2014.02.556_bib37) 2011; 123 Ussia (10.1016/j.jacc.2014.02.556_bib9) 2012; 33 Sack (10.1016/j.jacc.2014.02.556_bib20) 2008; 97 Charlson (10.1016/j.jacc.2014.02.556_bib11) 1987; 40 Folstein (10.1016/j.jacc.2014.02.556_bib15) 1975; 12 Binder (10.1016/j.jacc.2014.02.556_bib32) 2013; 62 Genereux (10.1016/j.jacc.2014.02.556_bib5) 2012; 59 Hahn (10.1016/j.jacc.2014.02.556_bib29) 2013; 61 Bohannon (10.1016/j.jacc.2014.02.556_bib13) 2007; 30 |
| References_xml | – volume: 107 start-page: 747 year: 2011 end-page: 754 ident: bib35 article-title: Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation publication-title: Am J Cardiol – volume: 364 start-page: 2187 year: 2011 end-page: 2198 ident: bib7 article-title: Transcatheter versus surgical aortic-valve replacement in high-risk patients publication-title: N Engl J Med – volume: 61 start-page: 2514 year: 2013 end-page: 2521 ident: bib29 article-title: Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (Placement of Aortic Transcatheter Valves) publication-title: J Am Coll Cardiol – volume: 57 start-page: 1650 year: 2011 end-page: 1657 ident: bib8 article-title: 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis publication-title: J Am Coll Cardiol – volume: 95 start-page: 43 year: 2005 end-page: 47 ident: bib17 article-title: Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years publication-title: Am J Cardiol – volume: 75 start-page: 794 year: 2010 end-page: 798 ident: bib23 article-title: Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty publication-title: Catheter Cardiovasc Interv – volume: 185 start-page: 914 year: 1963 end-page: 919 ident: bib14 article-title: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function publication-title: JAMA – volume: 33 start-page: 684 year: 2012 end-page: 689 ident: bib9 article-title: Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis publication-title: Eur Heart J – volume: 57 start-page: 253 year: 2011 end-page: 269 ident: bib16 article-title: Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium publication-title: J Am Coll Cardiol – volume: 24 start-page: 881 year: 2003 end-page: 882 ident: bib27 article-title: The logistic EuroSCORE publication-title: Eur Heart J – volume: 61 start-page: 1585 year: 2013 end-page: 1595 ident: bib31 article-title: Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature publication-title: J Am Coll Cardiol – volume: 88 start-page: S23 year: 2009 end-page: S42 ident: bib10 article-title: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery publication-title: Ann Thoracic Surg – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: bib11 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis – volume: 19 start-page: 269 year: 2006 end-page: 275 ident: bib18 article-title: Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis publication-title: J Interv Cardiol – volume: 123 start-page: 951 year: 2011 end-page: 960 ident: bib37 article-title: Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative) publication-title: Circulation – volume: 48 start-page: e1 year: 2006 end-page: e148 ident: bib2 article-title: ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons publication-title: J Am Coll Cardiol – volume: 58 start-page: 445 year: 2011 end-page: 455 ident: bib24 article-title: Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons publication-title: J Am Coll Cardiol – volume: 61 start-page: 1125 year: 2013 end-page: 1136 ident: bib30 article-title: Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature publication-title: J Am Coll Cardiol – volume: 6 start-page: 475 year: 2010 end-page: 484 ident: bib39 article-title: Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation publication-title: EuroIntervention – volume: 97 start-page: 288 year: 2008 end-page: 297 ident: bib20 article-title: Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly publication-title: Clin Res Cardiol – volume: 56 start-page: 1668 year: 2010 end-page: 1676 ident: bib12 article-title: Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery publication-title: J Am Coll Cardiol – volume: 59 start-page: 1275 year: 2012 end-page: 1286 ident: bib33 article-title: Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation publication-title: J Am Coll Cardiol – volume: 59 start-page: 2317 year: 2012 end-page: 2326 ident: bib5 article-title: Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies publication-title: J Am Coll Cardiol – volume: 366 start-page: 1696 year: 2012 end-page: 1704 ident: bib6 article-title: Transcatheter aortic-valve replacement for inoperable severe aortic stenosis publication-title: N Engl J Med – volume: 19 start-page: 1 year: 2007 end-page: 5 ident: bib19 article-title: Current results of balloon aortic valvuloplasty in high-risk patients publication-title: J Invasive Cardiol – volume: 17 start-page: 468 year: 2008 end-page: 474 ident: bib21 article-title: Balloon aortic valvuloplasty in adults—a 10-year review of Auckland's experience publication-title: Heart Lung Circ – volume: 5 start-page: 974 year: 2012 end-page: 981 ident: bib26 article-title: The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience publication-title: J Am Coll Cardiol Intv – volume: 59 start-page: 1200 year: 2012 end-page: 1254 ident: bib25 article-title: 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement publication-title: J Am Coll Cardiol – volume: 23 start-page: 391 year: 2012 end-page: 397 ident: bib36 article-title: Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature publication-title: J Cardiovasc Electrophysiol – volume: 26 start-page: 2714 year: 2005 end-page: 2720 ident: bib3 article-title: Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? publication-title: Eur Heart J – volume: 30 start-page: 28 year: 2007 end-page: 30 ident: bib13 article-title: Average grip strength: a meta-analysis of data obtained with a Jamar dynamometer from individuals 75 years or more of age publication-title: J Geriatr Phys Ther – volume: 137 start-page: 1430 year: 2009 end-page: 1435 ident: bib22 article-title: Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement publication-title: J Thorac Cardiovasc Surg – volume: 373 start-page: 956 year: 2009 end-page: 966 ident: bib1 article-title: Aortic stenosis publication-title: Lancet – volume: 62 start-page: 431 year: 2013 end-page: 438 ident: bib32 article-title: The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial publication-title: J Am Coll Cardiol – volume: 1 start-page: 310 year: 2008 end-page: 316 ident: bib34 article-title: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve publication-title: J Am Coll Cardiol Intv – volume: 8 start-page: 556 year: 2012 end-page: 562 ident: bib40 article-title: Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve Accutrak system publication-title: EuroIntervention – volume: 310 start-page: 2069 year: 2013 end-page: 2077 ident: bib28 article-title: Outcomes following transcatheter aortic valve replacement in the United States publication-title: JAMA – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: bib15 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res – volume: 363 start-page: 1597 year: 2010 end-page: 1607 ident: bib4 article-title: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery publication-title: N Engl J Med – volume: 60 start-page: 493 year: 2012 end-page: 501 ident: bib38 article-title: Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation publication-title: J Am Coll Cardiol – volume: 59 start-page: 1275 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib33 article-title: Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.11.045 – volume: 137 start-page: 1430 year: 2009 ident: 10.1016/j.jacc.2014.02.556_bib22 article-title: Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2008.12.030 – volume: 61 start-page: 1125 year: 2013 ident: 10.1016/j.jacc.2014.02.556_bib30 article-title: Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.08.1039 – volume: 1 start-page: 310 year: 2008 ident: 10.1016/j.jacc.2014.02.556_bib34 article-title: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2008.04.007 – volume: 26 start-page: 2714 year: 2005 ident: 10.1016/j.jacc.2014.02.556_bib3 article-title: Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi471 – volume: 48 start-page: e1 year: 2006 ident: 10.1016/j.jacc.2014.02.556_bib2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.05.021 – volume: 33 start-page: 684 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib9 article-title: Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis publication-title: Eur Heart J doi: 10.1093/eurheartj/ehr491 – volume: 95 start-page: 43 year: 2005 ident: 10.1016/j.jacc.2014.02.556_bib17 article-title: Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.08.061 – volume: 40 start-page: 373 year: 1987 ident: 10.1016/j.jacc.2014.02.556_bib11 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 310 start-page: 2069 year: 2013 ident: 10.1016/j.jacc.2014.02.556_bib28 article-title: Outcomes following transcatheter aortic valve replacement in the United States publication-title: JAMA doi: 10.1001/jama.2013.282043 – volume: 57 start-page: 1650 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib8 article-title: 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.11.044 – volume: 57 start-page: 253 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib16 article-title: Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.12.005 – volume: 56 start-page: 1668 year: 2010 ident: 10.1016/j.jacc.2014.02.556_bib12 article-title: Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.06.039 – volume: 75 start-page: 794 year: 2010 ident: 10.1016/j.jacc.2014.02.556_bib23 article-title: Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty publication-title: Catheter Cardiovasc Interv doi: 10.1002/ccd.22355 – volume: 60 start-page: 493 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib38 article-title: Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.03.054 – volume: 97 start-page: 288 year: 2008 ident: 10.1016/j.jacc.2014.02.556_bib20 article-title: Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly publication-title: Clin Res Cardiol doi: 10.1007/s00392-008-0650-0 – volume: 19 start-page: 269 year: 2006 ident: 10.1016/j.jacc.2014.02.556_bib18 article-title: Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis publication-title: J Interv Cardiol doi: 10.1111/j.1540-8183.2006.00142.x – volume: 366 start-page: 1696 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib6 article-title: Transcatheter aortic-valve replacement for inoperable severe aortic stenosis publication-title: N Engl J Med doi: 10.1056/NEJMoa1202277 – volume: 12 start-page: 189 year: 1975 ident: 10.1016/j.jacc.2014.02.556_bib15 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 – volume: 19 start-page: 1 year: 2007 ident: 10.1016/j.jacc.2014.02.556_bib19 article-title: Current results of balloon aortic valvuloplasty in high-risk patients publication-title: J Invasive Cardiol – volume: 123 start-page: 951 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib37 article-title: Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.927152 – volume: 6 start-page: 475 year: 2010 ident: 10.1016/j.jacc.2014.02.556_bib39 article-title: Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation publication-title: EuroIntervention doi: 10.4244/EIJ30V6I4A80 – volume: 373 start-page: 956 year: 2009 ident: 10.1016/j.jacc.2014.02.556_bib1 article-title: Aortic stenosis publication-title: Lancet doi: 10.1016/S0140-6736(09)60211-7 – volume: 107 start-page: 747 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib35 article-title: Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2010.10.054 – volume: 364 start-page: 2187 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib7 article-title: Transcatheter versus surgical aortic-valve replacement in high-risk patients publication-title: N Engl J Med doi: 10.1056/NEJMoa1103510 – volume: 185 start-page: 914 year: 1963 ident: 10.1016/j.jacc.2014.02.556_bib14 article-title: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function publication-title: JAMA doi: 10.1001/jama.1963.03060120024016 – volume: 363 start-page: 1597 year: 2010 ident: 10.1016/j.jacc.2014.02.556_bib4 article-title: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1008232 – volume: 17 start-page: 468 year: 2008 ident: 10.1016/j.jacc.2014.02.556_bib21 article-title: Balloon aortic valvuloplasty in adults—a 10-year review of Auckland's experience publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2008.06.002 – volume: 61 start-page: 2514 year: 2013 ident: 10.1016/j.jacc.2014.02.556_bib29 article-title: Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (Placement of Aortic Transcatheter Valves) publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.02.087 – volume: 59 start-page: 1200 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib25 article-title: 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.01.001 – volume: 61 start-page: 1585 year: 2013 ident: 10.1016/j.jacc.2014.02.556_bib31 article-title: Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.01.047 – volume: 58 start-page: 445 year: 2011 ident: 10.1016/j.jacc.2014.02.556_bib24 article-title: Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.05.007 – volume: 59 start-page: 2317 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib5 article-title: Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.02.022 – volume: 23 start-page: 391 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib36 article-title: Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2011.02211.x – volume: 5 start-page: 974 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib26 article-title: The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience publication-title: J Am Coll Cardiol Intv doi: 10.1016/j.jcin.2012.06.011 – volume: 24 start-page: 881 year: 2003 ident: 10.1016/j.jacc.2014.02.556_bib27 article-title: The logistic EuroSCORE publication-title: Eur Heart J doi: 10.1016/S0195-668X(02)00799-6 – volume: 88 start-page: S23 year: 2009 ident: 10.1016/j.jacc.2014.02.556_bib10 article-title: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery publication-title: Ann Thoracic Surg doi: 10.1016/j.athoracsur.2009.05.056 – volume: 8 start-page: 556 year: 2012 ident: 10.1016/j.jacc.2014.02.556_bib40 article-title: Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve Accutrak system publication-title: EuroIntervention doi: 10.4244/EIJV8I5A86 – volume: 62 start-page: 431 year: 2013 ident: 10.1016/j.jacc.2014.02.556_bib32 article-title: The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.04.036 – volume: 30 start-page: 28 year: 2007 ident: 10.1016/j.jacc.2014.02.556_bib13 article-title: Average grip strength: a meta-analysis of data obtained with a Jamar dynamometer from individuals 75 years or more of age publication-title: J Geriatr Phys Ther doi: 10.1519/00139143-200704000-00006 |
| SSID | ssj0006819 |
| Score | 2.6349738 |
| Snippet | This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients... ObjectivesThis study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in... This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients... Objectives This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1972 |
| SubjectTerms | Aged Aged, 80 and over aortic stenosis Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - surgery Aspirin Biological and medical sciences Bioprosthesis - standards Cardiac Catheterization - instrumentation Cardiac Catheterization - methods Cardiology Cardiology. Vascular system Cardiovascular Catheters Female Follow-Up Studies Heart Heart Valve Prosthesis - standards Heart Valve Prosthesis Implantation - instrumentation Heart Valve Prosthesis Implantation - methods Humans Male Medical imaging Medical prognosis Medical sciences Mortality outcomes Patients Prospective Studies Prosthesis Design - standards Risk Factors Severity of Illness Index Stroke Surgery transcatheter aortic valve replacement Treatment Outcome |
| Title | Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0735109714013965 https://www.clinicalkey.es/playcontent/1-s2.0-S0735109714013965 https://dx.doi.org/10.1016/j.jacc.2014.02.556 https://www.ncbi.nlm.nih.gov/pubmed/24657695 https://www.proquest.com/docview/1523894151 https://www.proquest.com/docview/1525763400 |
| Volume | 63 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKDwgJIf7ZUlZG4obCbhI7P8e22qpCKkKEwt4sOxmraVfZVZOinngInmCfZZ-MGeenqihF4phknDj2ePzZnm-GsXdSFGJamMIzqUg9AUXqGRFZL_chDnRohXBONMefoqMT8XEu51vsoOfCkFtlZ_tbm-6sdXdn0rXmZFWWkwyVU9L5qVsipBERzUOROBLffH-wxlHiknuQsEfSHXGm9fE60zmFMfQFxe2UlMT69snp4UrX2GS2zXXxdzDqJqXDx-xRhyb5XlvhJ2wLqqfs_nF3Xv6M_XJTkQvNiu3H95YkyL_pxQ_gCL1pC512B7lzHNis9WadwcJ6s6tVy3bh--VyRbyQU6jLmpcV_9zGYa3597I55RngSID-vVlDkcdRTjd8dtXQzuNm_aWszzkiY561BOzn7ORw9vXgyOuyMHi5DKaNB0liklhbX_iJLSg5eQSR1saAKQCiwMRxbiGwJrIU_63wba6FzVE3UA8SKcMXbLtaVvCKcconAz4KFggcICEHaFwRGR0jiIDIpCPm982v8i5EOWXKWKjeF-1MUZcp6jI1DRR22Yi9H8qs2gAdd0qHfa-qnnqKxlLh_HFnqfi2UlB3471WvqoDNVV_6OSIyaHkDbX-5xfHN1Ru-DUivCYyQYHdXgfVdS0kArAUIZk_Ym-Hx2gv6BBIV7C8dDK4xAzRdI_Yy1Z3r18uInyWyp3_rPVr9oCuyLkimO6y7ebiEt4gZmvMmN378NMfu6H5G8YTQ7M |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVKkQAJIW6FQClG4g2FTbJ2Lo-l2mqBboXYFvpm2clYTVllI5KiPvERfMF-y34ZM7nsqqIUidd4JnHsmfGxPRfGXkuRCS8zmWsSkbgCssQ1IrRu6kMU6KEVonGimRyG42Px4USebLC9PhaG3Co729_a9MZad08G3WgOyjwfTFE4Jd2fNluEJJQ32E2B6kva-fbn2s8jjJvqHkTtEnkXOdM6eZ3plPIY-oISd0qqYn316nS31BWOmW2LXfwdjTar0v59dq-Dk3y37fEDtgHFQ3Zr0l2YP2K_mrWoyc2KA8h350TIv-jZD-CIvekMnY4HeeM5sFzo5WIKM-uOLso23IW_y-clBYacQpVXPC_4pzYRa8W_5vUpnwKqAvTvndaUehzpdM1HFzUdPS4Xn_PqG0dozKdtBPZjdrw_Otobu10ZBjeVgVe7EMcmjrT1hR_bjKqThxBqbQyYDCAMTBSlFgJrQksJ4DLfplrYFIUDBSGWcrjFNot5AU8Zp4Iy4CNhhsgBYvKAxi2R0RGiCAhN4jC_H36VdjnKqVTGTPXOaGeKpkzRlCkvUDhlDnuz4inbDB3XUg_7WVV97ClaS4ULyLVc0VVcUHUKXylfVYHy1B9C6TC54rwk1__84s4lkVv9GkW8xjJGgu1eBtW6FxIRWIKYzHfYq1UzGgy6BdIFzM8bGtxjDtF2O-xJK7vrl4sQ2xL57D97_ZLdHh9NDtTB-8OPz9kdaiFPi8DbZpv193N4gQCuNjuNgv4GQS9Fxw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcatheter+Aortic+Valve+Replacement+Using%C2%A0a%C2%A0Self-Expanding+Bioprosthesis+in+Patients+With+Severe+Aortic+Stenosis+at+Extreme%C2%A0Risk+for+Surgery&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Popma%2C+Jeffrey+J.&rft.au=Adams%2C+David+H.&rft.au=Reardon%2C+Michael+J.&rft.au=Yakubov%2C+Steven+J.&rft.date=2014-05-20&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=63&rft.issue=19&rft.spage=1972&rft.epage=1981&rft_id=info:doi/10.1016%2Fj.jacc.2014.02.556&rft.externalDocID=S0735109714013965 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109714X00318%2Fcov150h.gif |